Dasan Pharmaceutical has embarked on mutual cooperation with Suwon Special City to expand research and development (R&D) facilities and advance the local bio industry.


Dasan Pharmaceutical Signs Investment Agreement with Suwon City...Expanding R&D Facilities View original image

According to Dasan Pharmaceutical on July 7, this investment agreement was arranged as part of Suwon City’s policy to foster an advanced bio ecosystem and revitalize the local economy.


Dasan Pharmaceutical plans to expand its R&D facilities within Suwon City and strengthen its research and development capabilities to develop next-generation formulation technologies and expand its global CDMO business. Suwon City intends to provide administrative and financial support in accordance with the “Ordinance and Enforcement Rules on the Promotion of Corporate Attraction and Investment Support in Suwon City” so that the expansion of Dasan Pharmaceutical’s R&D facilities can proceed smoothly.


Since its establishment in 1996, Dasan Pharmaceutical has grown based on its business in active pharmaceutical ingredients (APIs), finished pharmaceutical products, formulation research and development, and contract manufacturing. In particular, leveraging formulation technology based on drug delivery systems (DDS) and manufacturing capabilities for solid preparations, the company is expanding its business scope as a technology-driven CDMO that supports customer companies from product development stages to commercial production, beyond simple contract manufacturing.


Dasan Pharmaceutical plans to make active use of Suwon City’s bio and healthcare industry infrastructure and specialized research talent base. Notably, in January, Dasan Pharmaceutical was selected for an advanced medical industry demonstration support project organized by the Ministry of Health and Welfare, and is currently conducting efficacy and safety evaluations for a Gapmer ASO (Anti-Sense Oligonucleotide) new drug candidate with a PCSK9 inhibitory mechanism.



Ryu Hyeongseon, CEO of Dasan Pharmaceutical, stated, “The bio infrastructure and specialized research talent possessed by Suwon City will serve as a crucial foundation for Dasan Pharmaceutical’s future growth,” adding, “Through this investment agreement, we will strengthen our R&D capabilities and, as a member of Suwon City's advanced bio ecosystem, contribute to local economic development and job creation.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing